Rodríguez Faba O, Martín Benito J L, Escaf Barmadah S, Rodríguez Martínez J J, Jalón Monzón A, Regadera Sejas J
Servicio de Urología I, Hospital Universitario Central de Asturias, Oviedo, Asturias.
Actas Urol Esp. 2004 Sep;28(8):575-80. doi: 10.1016/s0210-4806(04)73137-x.
The aim of this study was to review the current situation of penile prosthesis in the treatment of erectile dysfunction and to analyze the indications, degree of acceptability and complications in our experience.
From 1984 to 2003, 48 implants were inserted in men suffering from impotence due to different etiologies. The mean age was 55 years. Vascular disease, Diabetes and pelvic surgery were the most common pathologies recorded. The type of prothesis inserted were malleable inactive in 7 cases (14.58%), Jonas6, Acu-form1. Inflable active with 3 components in 19 cases (39.58%), AMS 700 plus17, Alpha2. Inflable active integrated in 5 cases (10.41%) Hydroflex4, Dynaflex1. Inflable active with 2 components in 17 cases (35.4%), Ambicor2, Mark II15.
Infection of the prosthesis was observed in 6.25% of the cases. This infectious complication required removal of the prosthesis. 4.16% of the cases complained of mechanical failure that required change of the prosthesis. 80% of the patients were satisfied with the results.
Penile prostheses continue to be an effective and valid therapeutic alternative in impotent. Although the complication rate is low, adequate information must be provided to the patient.
本研究旨在回顾阴茎假体治疗勃起功能障碍的现状，并根据我们的经验分析其适应证、可接受程度及并发症。
1984年至2003年，对因不同病因导致阳痿的男性患者植入了48个假体。平均年龄为55岁。记录到的最常见病因是血管疾病、糖尿病和盆腔手术。植入的假体类型包括：7例（14.58%）可弯曲非活性假体，Jonas6、Acu-form1；19例（39.58%）三件式可膨胀活性假体，AMS 700 plus17、Alpha2；5例（10.41%）一体化可膨胀活性假体，Hydroflex4、Dynaflex1；17例（35.4%）两件式可膨胀活性假体，Ambicor2、Mark II15。
6.25%的病例观察到假体感染。这种感染性并发症需要移除假体。4.16%的病例出现机械故障，需要更换假体。80%的患者对结果满意。
阴茎假体仍然是治疗阳痿的一种有效治疗选择。尽管并发症发生率较低，但必须向患者提供充分的信息。
